PhaseBio Pharmaceuticals, Inc.
Metalloenzyme inhibitor compounds
Last updated:
Abstract:
Provided are compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes.
Status:
Grant
Type:
Utility
Filling date:
17 Jan 2020
Issue date:
5 Oct 2021